3W Partners Founded -
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$78M
Portfolio companies 2
Lead investments 1
Exits 1
Stages of investment
Late Stage Venture
Private Equity
Areas of investment
Biotechnology
Health Care
Industrial
Lifestyle
Summary

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Health Care, Big Data. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Twist Bioscience, WuXi NextCODE.

The important activity for fund was in 2017. The increased amount of exits for fund were in 2018. Opposing the other organizations, this 3W Partners works on 38 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 50 - 100 millions dollars are the general things for fund.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the 3W Partners, startups are often financed by Asset Management Ventures (AMV), ARCH Venture Partners, Paladin Capital Group. The meaningful sponsors for the fund in investment in the same round are YF Capital (Yunfeng Capital), Temasek Holdings, Sequoia Capital. In the next rounds fund is usually obtained by YF Capital (Yunfeng Capital), Temasek Holdings, Sequoia Capital.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
CANbridge Pharmaceuticals
Biotechnology
Health Care
Pharmaceutical
Late Stage Venture
43M01 Dec 2020 China, Dongcheng District
Early Stage Venture
165M05 Sep 2017
Twist Bioscience
Biotechnology
Chemical
Health Care
Life Science
Venture - Series Unknown
27M14 Jun 2017 United States, San Francisco
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent 3W Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: